For patients managing blood clotting risks, this generic medicine inhibits thrombin activity to promote fluid blood flow and lower the risk of unwanted clotting events.
Information related to Pradaxa is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.